Polynovo Stock

Polynovo Debt 2024

Polynovo Debt

-30.53 AUD

Ticker

PNV.AX

ISIN

AU000000PNV0

WKN

A12F4T

In 2024, Polynovo's total debt was -30.53 AUD, a -723.98% change from the 4.89 AUD total debt recorded in the previous year.

Polynovo Aktienanalyse

What does Polynovo do?

Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Polynovo's Debt Structure

Polynovo's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Polynovo's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Polynovo’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Polynovo’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Polynovo stock

What is the debt of Polynovo this year?

Polynovo has a debt level of -30.53 AUD this year.

What was the debt of Polynovo compared to the previous year?

The debt of Polynovo has increased by -723.98% compared to the previous year dropped.

What are the consequences of high debt for investors in Polynovo?

High debt can pose a risk for investors of Polynovo, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Polynovo?

Low debt means that Polynovo has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Polynovo affect the company?

An increase in debt of Polynovo can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Polynovo affect the company?

A reduction in debt of Polynovo can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Polynovo?

Some factors that can influence the debt of Polynovo include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Polynovo so important for investors?

The debts of Polynovo are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Polynovo take to change the debt?

To change the debt, Polynovo can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Polynovo pay?

Over the past 12 months, Polynovo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Polynovo is expected to pay a dividend of 0 AUD.

What is the dividend yield of Polynovo?

The current dividend yield of Polynovo is .

When does Polynovo pay dividends?

Polynovo pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Polynovo?

Polynovo paid dividends every year for the past 0 years.

What is the dividend of Polynovo?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Polynovo located?

Polynovo is assigned to the 'Health' sector.

Wann musste ich die Aktien von Polynovo kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Polynovo from 12/20/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 12/20/2024.

When did Polynovo pay the last dividend?

The last dividend was paid out on 12/20/2024.

What was the dividend of Polynovo in the year 2023?

In the year 2023, Polynovo distributed 0 AUD as dividends.

In which currency does Polynovo pay out the dividend?

The dividends of Polynovo are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Polynovo

Our stock analysis for Polynovo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Polynovo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.